Home › Funds › Syncona Portfolio Ltd › AUTL

Syncona Portfolio Ltd position in AUTL

AUTOLUS THERAPEUTICS LTD · Health Care

Syncona Portfolio Ltd reported holding 16,640,720 shares of AUTL (AUTOLUS THERAPEUTICS LTD) in its Q3 2026 13F filing — a position valued at US$32.3M, representing 100.00% of its reported portfolio and ranking #1 among its reported holdings. Syncona Portfolio Ltd has disclosed AUTL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)16.64M sh
Reported value held$32.28M
Portfolio Weight100.00%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Syncona Portfolio Ltd's AUTL position evolved

Syncona Portfolio Ltd first disclosed a stake in AUTL in Q3 2023 at 21,346,829 shares (US$49.7M). The position peaked in Q4 2023 at 21,346,829 shares, worth US$137.5M. Across 13 filings, Syncona Portfolio Ltd increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 10 time(s). The most recent filing (Q3 2026) shows 16,640,720 shares valued at US$32.3M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 21.35M $49.74M New
Q4 2023 21.35M $137.47M Hold
Q1 2024 21.35M $136.19M Hold
Q2 2024 21.35M $74.29M Hold
Q3 2024 18.55M $67.35M Reduce
Q4 2024 16.64M $39.11M Reduce
Q1 2025 16.64M $25.79M Hold
Q2 2025 16.64M $37.94M Hold
Q3 2025 16.64M $27.12M Hold
Q4 2025 16.64M $33.12M Hold
Q1 2026 16.64M $22.96M Hold
Q2 2026 16.64M $26.63M Hold
Q3 2026 16.64M $32.28M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AUTL and 13F data

AUTL (AUTOLUS THERAPEUTICS LTD) is a Health Care company. 18 other funds we track also report a position in AUTL — the largest reported positions include MAK CAPITAL ONE LLC (US$53.8M), ARMISTICE CAPITAL, LLC (US$24.0M), Tetragon Partners GP Ltd (US$15.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AUTL

All AUTL fund holders →

FAQ

How long has Syncona Portfolio Ltd held AUTL?

Syncona Portfolio Ltd has disclosed AUTL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Syncona Portfolio Ltd's current position in AUTL?

As of Q3 2026, Syncona Portfolio Ltd holds 16.64M shares of AUTL (AUTOLUS THERAPEUTICS LTD), valued at $32.28M, representing 100.00% of its reported portfolio and ranking #1.

Has Syncona Portfolio Ltd been buying or selling AUTL?

In the latest 13F filing (Q3 2026), Syncona Portfolio Ltd held unchanged its position in AUTL. The position peaked in Q4 2023 at 21.35M shares.

Which other funds hold AUTL?

Other major institutional holders of AUTL include MAK CAPITAL ONE LLC, ARMISTICE CAPITAL, LLC, Tetragon Partners GP Ltd, among 18 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.